161117-88-0 Usage
General Description
CARBAMIC ACID, (5-NITRO-2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER is a chemical compound with the molecular formula C9H12N4O4. It is commonly used as a pesticide and herbicide. CARBAMIC ACID, (5-NITRO-2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER is a contact and stomach insecticide with both systemic and residual activity. It is also effective against a wide range of pests, including aphids, thrips, beetles, and caterpillars. However, it is important to handle this chemical with caution as it is toxic to aquatic organisms and may have long-lasting effects in the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 161117-88-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,1,1 and 7 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 161117-88:
(8*1)+(7*6)+(6*1)+(5*1)+(4*1)+(3*7)+(2*8)+(1*8)=110
110 % 10 = 0
So 161117-88-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H13N3O4/c1-10(2,3)17-9(14)12-8-5-4-7(6-11-8)13(15)16/h4-6H,1-3H3,(H,11,12,14)
161117-88-0Relevant articles and documents
Discovery of novel heterocyclic factor VIIa inhibitors
Rai, Roopa,Kolesnikov, Aleksandr,Sprengeler, Paul A.,Torkelson, Steven,Ton, Tony,Katz, Bradley A.,Yu, Christine,Hendrix, John,Shrader, William D.,Stephens, Robin,Cabuslay, Ronnell,Sanford, Ellen,Young, Wendy B.
, p. 2270 - 2273 (2006)
Structure-activity relationships and binding mode of novel heterocyclic factor VIIa inhibitors will be described. In these inhibitors, a highly basic 5-amidinoindole moiety has been successfully replaced with a less basic 5-aminopyrrolo[3,2-b]pyridine sca
PLATELET ADP RECEPTOR INHIBITORS
-
Paragraph 0132, (2016/08/17)
no abstract published
TYK2 INHIBITORS AND USES THEREOF
-
Paragraph 001167; 001168, (2015/09/28)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.